Prospective, multicenter, controlled trial of mobile stroke units
New England Journal of Medicine Sep 13, 2021
Grotta JC, Yamal JM, Parker SA, et al. - In patients with acute stroke who were eligible for tissue plasminogen activator (t-PA), mobile stroke units (MSUs; ambulances with staff and a computed tomographic scanner) were noted to be linked with better utility-weighted disability outcomes at 90 days when compared with emergency medical services (EMS).
An observational, prospective, multicenter, alternating-week trial.
The score on the utility-weighted modified Rankin scale (range, 0 to 1, with higher scores indicating better outcomes according to a patient value system, derived from scores on the modified Rankin scale of 0 to 6, with higher scores indicating more disability) was the primary outcome.
A total of 1,515 patients were enrolled; 1,047 of these were eligible to receive t-PA.
MSU was involved in providing care to 617 patients and EMS was involved in providing care to 430 patients.
In the MSU vs EMS group, the median time from onset of stroke to administration of t-PA was 72 vs 108 minutes, t-PA was administered in 97.1% vs 79.5% of the patients, the mean score on the utility-weighted modified Rankin scale at 90 days was 0.72 vs 0.66, a score of 0 or 1 on the modified Rankin scale at 90 days was achieved by 55.0% vs 44.4%, mortality at 90 days was 8.9% vs 11.9%.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries